...
首页> 外文期刊>Circulation. Cardiovascular quality and outcomes >Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network
【24h】

Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network

机译:二尖瓣修复的成本效益与严重缺血二尖瓣重新改善的替代性临床试验从心胸外科试验网络中的随机临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The CTSN (Cardiothoracic Surgical Trials Network) recently reported no difference in left ventricular end-systolic volume index or in survival at 2 years between patients with severe ischemic mitral regurgitation (MR) randomized to mitral valve repair or replacement. However, replacement provided more durable correction of MR and fewer cardiovascular readmissions. Yet, cost-effectiveness outcomes have not been addressed.
机译:背景:CTSN(心胸外科手术试验网络)最近报告左心室结束 - 收缩卷指数没有差异,在严重缺血二尖瓣重新改性(MR)对二尖瓣修复或更换的患者之间的患者之间存在生存。 但是,更换提供了更耐用的先生和更少的心血管入伍矫正。 然而,尚未解决成本效益结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号